Mustang licenses immunodeficiency gene therapy from St. Jude

Mustang licenses immunodeficiency gene therapy from St. Jude

Submitted by admin on August 15, 2018 - 10:55pm
Source: 
BioCentury
News Tags: 
Mustang Bio
lentiviral
gene therapy
SCID
St Jude Children's Hospital
Headline: 
Mustang licenses immunodeficiency gene therapy from St. Jude
snippet: 

Mustang Bio Inc. (NASDAQ:MBIO) gained exclusive, worldwide rights to develop and commercialize an ex vivo lentiviral gene therapy to treat X-linked severe combined immunodeficiency (SCID) from St. Jude Children's Research Hospital.

Do Not Allow Advertisers to Use My Personal information